Charles Schwab’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $7.2B | Buy |
6,001,955
+104,505
| +2% | +$107M | 0.96% | 14 |
|
|
2026
Q1 | $5.42B | Buy |
5,897,450
+139,244
| +2% | +$141M | 0.83% | 25 |
|
|
2025
Q4 | $6.19B | Buy |
5,758,206
+125,815
| +2% | +$120M | 0.96% | 12 |
|
|
2025
Q3 | $4.3B | Buy |
5,632,391
+272,738
| +5% | +$203M | 0.69% | 26 |
|
|
2025
Q2 | $4.18B | Buy |
5,359,653
+112,105
| +2% | +$87.1M | 0.72% | 26 |
|
|
2025
Q1 | $4.33B | Buy |
5,247,548
+212,464
| +4% | +$177M | 0.81% | 25 |
|
|
2024
Q4 | $3.89B | Buy |
5,035,084
+199,864
| +4% | +$165M | 0.72% | 25 |
|
|
2024
Q3 | $4.28B | Buy |
4,835,220
+10,204
| +0.2% | +$9.17M | 0.82% | 22 |
|
|
2024
Q2 | $4.37B | Buy |
4,825,016
+150,756
| +3% | +$121M | 0.83% | 17 |
|
|
2024
Q1 | $3.64B | Buy |
4,674,260
+113,707
| +2% | +$80.9M | 0.84% | 17 |
|
|
2023
Q4 | $2.66B | Buy |
4,560,553
+125,242
| +3% | +$73.1M | 0.68% | 27 |
|
|
2023
Q3 | $2.38B | Buy |
4,435,311
+88,016
| +2% | +$45.4M | 0.68% | 27 |
|
|
2023
Q2 | $2.04B | Buy |
4,347,295
+33,311
| +0.8% | +$14M | 0.58% | 32 |
|
|
2023
Q1 | $1.48B | Buy |
4,313,984
+31,847
| +0.7% | +$10.7M | 0.45% | 37 |
|
|
2022
Q4 | $1.57B | Buy |
4,282,137
+74,736
| +2% | +$26.5M | 0.5% | 35 |
|
|
2022
Q3 | $1.36B | Buy |
4,207,401
+370,521
| +10% | +$117M | 0.49% | 34 |
|
|
2022
Q2 | $1.24B | Sell |
3,836,880
-32,394
| -0.8% | -$9.72M | 0.43% | 40 |
|
|
2022
Q1 | $1.11B | Buy |
3,869,274
+83,299
| +2% | +$21.4M | 0.33% | 56 |
|
|
2021
Q4 | $1.05B | Buy |
3,785,975
+67,876
| +2% | +$17.2M | 0.31% | 64 |
|
|
2021
Q3 | $859M | Buy |
3,718,099
+52,452
| +1% | +$12.9M | 0.28% | 68 |
|
|
2021
Q2 | $841M | Buy |
3,665,647
+79,606
| +2% | +$16M | 0.28% | 67 |
|
|
2021
Q1 | $670M | Sell |
3,586,041
-3,041
| -0.1% | -$595K | 0.25% | 75 |
|
|
2020
Q4 | $606M | Buy |
3,589,082
+9,802
| +0.3% | +$1.46M | 0.24% | 81 |
|
|
2020
Q3 | $530M | Sell |
3,579,280
-309,768
| -8% | -$47.9M | 0.24% | 84 |
|
|
2020
Q2 | $639M | Buy |
3,889,048
+89,685
| +2% | +$13.8M | 0.31% | 59 |
|
|
2020
Q1 | $527M | Sell |
3,799,363
-69,027
| -2% | -$9.48M | 0.31% | 65 |
|
|
2019
Q4 | $508M | Sell |
3,868,390
-46,369
| -1% | -$5.37M | 0.27% | 68 |
|
|
2019
Q3 | $438M | Sell |
3,914,759
-66,340
| -2% | -$7.39M | 0.26% | 72 |
|
|
2019
Q2 | $441M | Sell |
3,981,099
-95,911
| -2% | -$11.3M | 0.27% | 68 |
|
|
2019
Q1 | $529M | Buy |
4,077,010
+17,875
| +0.4% | +$2.17M | 0.34% | 52 |
|
|
2018
Q4 | $470M | Sell |
4,059,135
-5,963
| -0.1% | -$666K | 0.36% | 47 |
|
|
2018
Q3 | $436M | Sell |
4,065,098
-122,303
| -3% | -$12.2M | 0.29% | 60 |
|
|
2018
Q2 | $357M | Sell |
4,187,401
-147,639
| -3% | -$12.1M | 0.26% | 66 |
|
|
2018
Q1 | $335M | Buy |
4,335,040
+85,455
| +2% | +$6.88M | 0.26% | 66 |
|
|
2017
Q4 | $359M | Buy |
4,249,585
+135,951
| +3% | +$11.6M | 0.28% | 57 |
|
|
2017
Q3 | $352M | Buy |
4,113,634
+553,349
| +16% | +$45.4M | 0.31% | 53 |
|
|
2017
Q2 | $293M | Buy |
3,560,285
+386,091
| +12% | +$31.5M | 0.28% | 57 |
|
|
2017
Q1 | $267M | Buy |
3,174,194
+228,673
| +8% | +$18.3M | 0.27% | 59 |
|
|
2016
Q4 | $217M | Buy |
2,945,521
+48,134
| +2% | +$3.58M | 0.24% | 72 |
|
|
2016
Q3 | $233M | Buy |
2,897,387
+19,660
| +0.7% | +$1.57M | 0.27% | 61 |
|
|
2016
Q2 | $227M | Sell |
2,877,727
-18,969
| -0.7% | -$1.43M | 0.28% | 59 |
|
|
2016
Q1 | $209M | Sell |
2,896,696
-690,206
| -19% | -$52.2M | 0.27% | 63 |
|
|
2015
Q4 | $302M | Buy |
3,586,902
+129,362
| +4% | +$10.7M | 0.41% | 44 |
|
|
2015
Q3 | $289M | Buy |
3,457,540
+316,393
| +10% | +$26.7M | 0.43% | 40 |
|
|
2015
Q2 | $262M | Buy |
3,141,147
+2,261
| +0.1% | +$172K | 0.36% | 53 |
|
|
2015
Q1 | $228M | Buy |
3,138,886
+139,074
| +5% | +$9.9M | 0.32% | 57 |
|
|
2014
Q4 | $207M | Sell |
2,999,812
-150,112
| -5% | -$10.1M | 0.31% | 54 |
|
|
2014
Q3 | $204M | Buy |
3,149,924
+93,158
| +3% | +$5.9M | 0.34% | 53 |
|
|
2014
Q2 | $190M | Buy |
3,056,766
+39,684
| +1% | +$2.37M | 0.32% | 59 |
|
|
2014
Q1 | $178M | Sell |
3,017,082
-204,464
| -6% | -$11.4M | 0.32% | 58 |
|
|
2013
Q4 | $164M | Buy |
3,221,546
+50,100
| +2% | +$2.51M | 0.31% | 61 |
|
|
2013
Q3 | $161M | Buy |
3,171,446
+108,142
| +4% | +$5.66M | 0.33% | 54 |
|
|
2013
Q2 | $154M | Buy |
+3,063,304
| New | +$167M | 0.34% | 55 |
|
Other funds holding LLY
Charles Schwab's LLY Position: Q2 2026 in Review
Charles Schwab increased its Eli Lilly (LLY) stake by 1.8% in Q2 2026, buying an estimated $107M and bringing the position to 6,001,955 shares worth $7.2B. The position accounts for 0.96% of the portfolio, ranked #14.
Charles Schwab first reported a position in LLY in Q2 2013 and has held it in 53 quarters since. 4,593 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Charles Schwab held 6,001,955 shares of Eli Lilly worth $7.2B as of Q2 2026.
- Charles Schwab bought 104,505 Eli Lilly shares in Q2 2026, an estimated $107M.
- Eli Lilly made up 0.96% of Charles Schwab's portfolio in Q2 2026, its #14 holding.
- Charles Schwab first reported a position in Eli Lilly in Q2 2013 and has held it in 53 quarters since.
- 4,593 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.